Ozempic (semaglutide for type 2 diabetes) and Mounjaro (tirzepatide for type 2 diabetes) are the same active ingredients as Wegovy and Zepbound, but they are FDA-approved for diabetes, not weight management
However, the active ingredient semaglutide is FDA-approved for weight loss, and compounded semaglutide offers the same clinical benefits as branded alternatives at a lower cost at $189/mo month-to-month, or from $149/mo on the 6-month plan
The slowed gastric emptying can lead to prolonged feelings of fullness, but when appetite returns, individuals might consume higher-calorie meals to compensate, particularly if they feel they have 'earned' extra food due to previous appetite suppression
Nevertheless, GLP-1 RAs have gastrointestinal adverse effects such as abdominal pain, constipation, diarrhea, nausea, and vomiting [7]